Medical devices, food supplements and cosmetics

Food Supplement Approval


We prepare the application dossiers required to place food supplements on the market in line with current regulations, communiqués and guidelines, and follow up the approval process.

Scope of service

Our scope of services

  • Preparation and follow-up of product approval dossiers
  • Regulatory compliance assessment of ingredients and daily amounts
  • Regulatory compliance review of labels and claims
  • Documentation and support for import procedures

Frequently asked questions

Common questions

Answers are based on the Implementing Instruction on Approval Procedures for Food Supplements (29.09.2026) of the General Directorate of Food and Control, Ministry of Agriculture and Forestry, and are for general information only. Current legislation and Ministry announcements prevail.

Is approval required for food supplements, and where is the application made?

Yes. Every food supplement to be placed on the market requires approval, including products manufactured or imported in bulk. For domestic production, the application is made to the Provincial Directorate of Agriculture and Forestry where the operator placing the product on the market under its own name and brand is located (if it operates in several provinces, the province of its head office in the trade registry); operators headquartered in Istanbul may also apply in Ankara, Bursa or Kocaeli. For imported products, the Ankara or Istanbul Provincial Directorate is competent, and approval must be obtained before the control certificate application for products subject to one, and before prior notification for others.

Which documents are required in the approval dossier?

The main documents under Annex 1 of the Implementing Instruction are:

  • Trade mark and name, percentage composition list, specification document and recommended daily intake dose
  • Undertaking that HACCP and/or GMP is applied at the manufacturing site; for contract manufacturing, the contract
  • Name, Latin name and part used of every botanical
  • TİTCK letter confirming that the brand and name are not those of a human medicinal product and comply with health claims legislation
  • Raw material specification and source declaration for all active ingredients (no source declaration is required for probiotics/postbiotics listed in the PMOL together with their manufacturer, or for botanicals on the Plant List and their extracts); undertaking that the auxiliary ingredients are not novel foods
  • Depending on the product: propolis process flow chart and analysis report, undertaking on the production method of plant oils, probiotic forms and stability data

Applications are made with a wet signature or via registered electronic mail (KEP); copies must bear a “true copy” stamp and wet signature, and each document must be submitted as a separately named PDF. A translation may be requested for documents in a foreign language.

How does the Novel Foods Regulation affect food supplements?

The Turkish Food Codex Regulation on Novel Foods entered into force on its publication in Official Gazette No. 33259 of 20 May 2026. If an ingredient not covered by the food supplement legislation or Annex 1 of the Regulation is to be used: if it is a novel food, an application is made under the Novel Foods Regulation; if not, the existing food supplement legislation applies; if in doubt, the General Directorate can be consulted before placing on the market. Ingredients whose specification is set in Annex 1 of the Regulation and whose use in food supplements is authorised are considered novel foods even if they were used in food supplements before 31/12/2025. By contrast, approval proceeds without requiring proof of use before 31/12/2025 for: active ingredients listed on the Restricted Substances List with their source/production method; ingredients authorised in Annex 1 for the food supplement category; ingredients listed in the PMOL together with their manufacturer; and botanicals on the Plant List, together with herbal preparations derived from them where no legal restriction applies.

How is use of an ingredient before 31/12/2025 proven?

If an active ingredient on the Restricted Substances List is obtained from a source or by a method not on the list, its use before 31/12/2025 must be proven with an unbroken chain of documents so that it is not treated as a novel food: for imported raw materials, manufacturer certificates of analysis, customs declarations and import documents; for domestic raw materials, producer records and producer receipts; where the raw material changed hands, invoices, delivery notes, warehouse records and distribution documents. Trade secrets may be redacted. The proof application is separate from, and precedes, the approval application; for probiotics and postbiotics it is made directly to the General Directorate, and for other active ingredients to the Provincial Directorate. For active ingredients produced by fermentation, the strain code of the microorganism and documents showing compliance with Biosafety Law No. 5977 must be included in the dossier; applications without a document confirming that the strain is not genetically modified are returned by the Provincial Directorate.

Which dates should be noted?

Key dates in the Implementing Instruction of 29 September 2026:

  • 1 February 2027: Deadline for applying to the Provincial Directorate for sources/methods of active ingredients (other than probiotics and postbiotics) that are not on the Restricted Substances List. After this date, proof of prior use alone is not sufficient and novel food status will be determined.
  • 30 June 2027: After this date, ingredients not listed on the Restricted Substances List with their source/production method may not be placed on the market, and approvals for such products are deactivated.
  • 30 June 2027: Deadline for approved products containing Annex 1 ingredients now classed as novel foods to comply with the Novel Foods Regulation.

The Restricted Substances List now also specifies the permitted source/production method for each active ingredient and is updated frequently. We recommend screening the ingredients of the approved products in your portfolio against the latest version of the list and these dates, and setting priorities.

What should be considered when choosing a product name and brand?

The product name must be consistent with its active ingredients; undeclared active ingredients may not be reflected in the name or brand. Brands of human medicinal products that are authorised, pending or cancelled may not be used, and a TİTCK letter on brand suitability is added to the dossier. The name of an active ingredient alone cannot be a brand (“ABCD Biotin”, not “Biotin”). The amount per consumption unit may appear in the name, but not the total daily amount (if 3 capsules provide 600 mg of vitamin C, “200 mg”). Bio, biyo, eco, eko and org may not be used for non-organic products. The name and net quantity must appear in Turkish in the principal field of vision of the label; “takviye edici gıda” (food supplement) is sufficient as the name.

Which changes to an approved product require a new approval?

A new approval is required if the trade mark, name, active ingredient or its amount per unit, the form, or the operator owning the product changes. The main changes that do not require a new approval are:

  • Different pack sizes (notification by petition is sufficient)
  • Formulation changes that do not alter the amount of active ingredient per unit or the form
  • A change of daily intake dose within the limits (except for ages 2–4/3–4) and the addition of a new user group
  • A change of manufacturer or contract manufacturer, or the addition of a new manufacturer
  • A change of trade name or address; switching from import to domestic production or vice versa

Updates are made by the Provincial Directorate that granted the approval; a separate fee is charged for each separate update request.

Are there different rules for products intended for children?

Yes. Applications for the 2–4/3–4 age group are forwarded by the Provincial Directorate to the General Directorate and assessed by the Food Supplements Commission. As additives are not permitted for ages 2–3, products containing additives are applied for ages 3–4 and those without additives for ages 2–4, with the corresponding statement on the label. For ages 4–10, tablets, capsules and pastilles other than shaped chewable forms and sucking, chewable and effervescent tablets are not approved; for ages 2–4/3–4, tablets and capsules other than effervescent tablets are not approved. Products containing royal jelly, bee pollen, perga, apilarnil or propolis are not approved for ages 2–4/3–4.

Who is responsible for health claims?

The assessment of health claims falls within the remit of TİTCK; Provincial Directorates do not assess health claims during approval. The operator placing the product on the market is responsible for the health claims used. If a breach of health claims legislation is found in the brand or name of an approved product, the product is re-approved under a new brand or name and the labels of products on the market are updated.

Get in touch

Let’s plan the next steps for your product

Tell us about your product, its current regulatory and pricing status and your target timeline, and we will get back to you promptly.